Manufacturing

Articles

PCI Pharma Services is investing $100 million in manufacturing capabilities and capacity expansion to its Bedford, NH facility.

PCI Pharma Services Invests $100 Million in Bedford, NH Manufacturing Facility 

Hallie Forcinio is packing editor for Pharmaceutical Technology and Pharmaceutical Technology Europe, editorhal@sbcglobal.net.

Exhibitors display primary packaging, secondary packaging, and machine innovations at this year’s INTERPHEX. 

INTERPHEX 2022 Moves Back to Spring-time Schedule

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

The continuous, aseptic fill/finish process is finding use in vaccines and biologic drugs. 

Considering Blow-Fill-Seal for Biologic Drugs

Curia and the US government have entered into a cooperative agreement to expand fill/finish capability for injectable medicines.

Curia Enters Cooperative Agreement with US Government to Expand Sterile Fill/Finish Capability

Moderna and Thermo Fisher Scientific have formed a collaboration to leverage dedicated commercial fill/finish manufacturing capacity in the US for mRNA vaccines and therapies.

Moderna and Thermo Fisher Scientific Form Long-Term Strategic Manufacturing Collaboration

Fareva plans to use blow-fill-seal equipment and ApiJect’s prefilled injector technology to create fill/finish capacity in France.

Fareva and ApiJect Plan Vaccine Packaging Capacity in France 

Global CDMO, ten23 health, has acquired filling technology and drug product manufacturing expert, swissfillon, enhancing its integrated offering.

ten23 health Acquires swissfillon to Enhance its Integrated Offering

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Alternative materials, as well as supply-chain planning, are essential to ensure a reliable supply for parenteral drug packaging.

Setting a Clear Strategy for Primary Packaging

Lonza plans to establish drug product manufacturing capabilities at is site in Guangzhou, China, to produce clinical trial and commercial supply in the country.

Lonza Invests in Drug Product Manufacturing Services in China

Recipharm has signed a memorandum of understanding (MOU) with His Majesty the King of Morocco, the Moroccan government, and a consortium of leading banks from the country, for fill/finish capacity in the country.

Fill-Finish